Ablaze Pharmaceuticals funding
Ablaze Pharmaceuticals funding profile: $75M total raised. Latest round: Series A. Backed by Vivo Capital, AdvanTech Capital, RAYZ Investments.
Headquarters: Shanghai, China
Investors
- Vivo Capital
- AdvanTech Capital
- RAYZ Investments
- Nan Fung Life Sciences
- Pivotal bioVenture Partners China
Fundraising guides
Browse the company funding database · Browse investors · Fundraising library
